Our guest: Panna Sharma, CEO & President at Lantern Pharma
"Lantern Pharma, Inc. is a clinical stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action, and also rescuing or revitalizing abandoned or failed cancer  drugs using machine learning techniques, genomic data and precision oncology trials."

In this episode, we discussed:

His background
Lantern Pharma's why-how-what 
Biden's drug pricing plan: what's missing and how can we take more steps to reform? 
What can we expect from the future of AI in cancer treatment? 
...and much more! 

Our sponsors for this episode are BlocHealth, Curation Health, ChenMed & MediTelecare.
BlocHealth is building the ecosystem of services and solutions to power the future of healthcare. For more information, please go to www.blochealth.com follow BlocHealth on social media - @blochealth
"Curation Health’s advanced clinical decision support platform seamlessly integrates into the electronic health record and leverages more than 750 proven clinical and quality rules. With this intelligent point-of-care platform, you can power a scalable risk adjustment process and amplify quality program performance." For more information, please go to www.curationhealthcare.com & follow Curation Health on social media - @curationhealth
"ChenMed brings concierge-style medicine and better health outcomes to the neediest populations – moderate-to-low income seniors with complex chronic diseases. For more information, please go to www.chenmed.com & follow ChenMed on social media - @chenmed
"MediTelecare provides behavioral telemedicine services to residents of skilled nursing and assisted living facilities, using state-of-the-art telehealth technology. For more information", please go to www.meditelecare.com & follow Meditelecare on social media – @meditelecare
To learn more about Lantern Pharma please use the links below:
- Website - LinkedIn - Twitter 
Also, be sure to follow Slice of Healthcare on our social channels:
- Website - Facebook - LinkedIn - Twitter - YouTube - Newsletter